(Q35129605)

6 August 2017

1 reference

title

Acute management of seizures in the syndromes of idiopathic generalized epilepsies (English)

1 reference

6 August 2017

Acute Management of Seizures in the Syndromes of Idiopathic Generalized Epilepsies (English)

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

3 January 2024

author name string

James W. Wheless

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752458

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752458

3 January 2024

publication date

1 January 2003

1 reference

full work available at URL

6 August 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1528-1157.44.s.2.5.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752458

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1528-1157.44.s.2.5.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1528-1157.44.s.2.5.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

3 January 2024

1 reference

6 August 2017

volume

44 Suppl 2

1 reference

6 August 2017

page(s)

22-26

1 reference

Valproate prevents the recurrence of absence status

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.44.S.2.5.X

Intravenous valproic acid for myoclonic status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.44.S.2.5.X

Myoclonic status epilepticus: video presentation.

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Efficacy and adverse effects of established and new antiepileptic drugs

3 January 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Absence Status A Reappraisal following Review of Thirty-eight Patients

3 January 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Typical absence status in adults: diagnostic and syndromic considerations

3 January 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Recurrent absence status epilepticus: clinical and EEG characteristics

3 January 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Nonconvulsion status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies

3 January 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

3 January 2024

Status epilepticus

11

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Intravenous loading of valproate for epilepsy

3 January 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes

3 January 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Antiepileptic drugs as a cause of worsening seizures

3 January 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Tiagabine overdose can induce convulsive status epilepticus

3 January 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment

3 January 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

3 January 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients

3 January 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine

3 January 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Myoclonic status epilepticus following high-dosage lamotrigine therapy

3 January 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Myoclonus and epilepsy in childhood: 1996 Royaumont meeting

3 January 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

Myoclonus associated with the use of gabapentin

3 January 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1528-1157.44.S.2.5.X

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference